Drug metabolism in chronic renal failure.

Abstract:

:Pharmacokinetic studies conducted in patients with CRF demonstrate that the nonrenal clearance of multiple drugs is reduced. Although the mechanism by which this occurs is unclear, several studies have shown that CRF affects the metabolism of drugs by inhibiting key enzymatic systems in the liver, intestine and kidney. The down-regulation of selected isoforms of the hepatic cytochrome P450 (CYP450) has been reported secondary to a decrease in gene expression. This is associated with major reductions in metabolism of drugs mediated by CYP450. The main hypothesis to explain the decrease in liver CYP450 activity in CRF appears to be the accumulation of circulating factors which can modulate CYP450 activity. Liver phase II metabolic reactions are also reduced in CRF. On the other hand, intestinal drug disposition is affected in CRF. Increased bioavailability of several drugs has been reported in CRF, reflecting decrease in either intestinal first-pass metabolism or extrusion of drugs (mediated by P-glycoprotein). Indeed, intestinal CYP450 is also down-regulated secondary to reduced gene expression, whereas, decreased intestinal P-glycoprotein activity has been described. Finally, although the kidneys play a major role in the excretion of drugs, it has the capacity to metabolize endogenous and exogenous compounds. CRF will lead to a decrease in the ability of the kidney to metabolize drugs, but the repercussions on the systemic clearance of drugs is still poorly defined, except for selected xenobiotics. In conclusion, reduced drug metabolism should be taken into account when evaluating the pharmacokinetics of drugs in patients with CRF.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Pichette V,Leblond FA

doi

10.2174/1389200033489532

keywords:

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

91-103

issue

2

eissn

1389-2002

issn

1875-5453

journal_volume

4

pub_type

杂志文章,评审
  • Transcriptome and proteome analyses of drug interactions with natural products.

    abstract::Advances in high-throughput technologies to measure genome-scale changes of genes, proteins, and other biomolecular components ('omics') in complex biological systems have dramatically revolutionized biomedical research. However, the benefits of utilizing omics information in drug development have not yet been fully r...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008786927802

    authors: Fang H,Wang K,Zhang J

    更新日期:2008-12-01 00:00:00

  • Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects.

    abstract:BACKGROUND:Wound healing is a composite and vital process in which devitalized tissue layers and cellular structures repair themselves. Bronchiolitis is generally prompted by respiratory syncytial virus or human metapneumovirus; this condition is an acute inflammatory injury of bronchioles. Heart problems that develop ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666151210124713

    authors: AlMatar M,Batool T,Makky EA

    更新日期:2016-01-01 00:00:00

  • Heterotropic cooperativity in oxidation mediated by cytochrome p450.

    abstract::Cytochrome P450s (P450 or CYPs) comprise a superfamily of enzymes that catalyze the oxidation of a wide variety of xenobiotic chemicals. Although most of P450 inhibitors decrease the metabolic activities mediated by the corresponding P450 forms, unexpected phenomena, which are called as activation or heterotropic coop...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008784746364

    authors: Niwa T,Murayama N,Yamazaki H

    更新日期:2008-06-01 00:00:00

  • Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

    abstract::The binding of drugs with serum proteins can affect the activity, distribution, rate of excretion, and toxicity of pharmaceutical agents in the body. One tool that can be used to quickly analyze and characterize these interactions is high-performance affinity chromatography (HPAC). This review shows how HPAC can be us...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011795202938

    authors: Hage DS,Anguizola J,Barnaby O,Jackson A,Yoo MJ,Papastavros E,Pfaunmiller E,Sobansky M,Tong Z

    更新日期:2011-05-01 00:00:00

  • Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease.

    abstract::A amyloid-β (Aβ) plaque formation in the brain is known to be the root cause of Alzheimer's disease (AD), which affects the behavior, memory, and cognitive ability in humans. The brain starts undergoing changes several years before the actual appearance of the symptoms. Nanotechnology could prove to be an alternative ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666201124140518

    authors: Chauhan PS,Yadav D,Koul B,Mohanta YK,Jin JO

    更新日期:2020-01-01 00:00:00

  • Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.

    abstract::Brain, the centre of the nervous system and an integral part the body, is protected by two anatomical and physiological barriers- Blood-Brain Barrier (BBB) and Blood-Cerebrospinal Fluid Barrier (BCSFB). Blood-Brain Barrier is a very complex and highly organized multicellular structure that shields the brain from harmf...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200218666170113125132

    authors: Sarkar A,Fatima I,Jamal QMS,Sayeed U,Khan MKA,Akhtar S,Kamal MA,Farooqui A,Siddiqui MH

    更新日期:2017-01-01 00:00:00

  • Active metabolites resulting from decarboxylation, reduction and ester hydrolysis of parent drugs.

    abstract::Decarboxylation, reduction and hydrolysis can yield active metabolites from the parent drug. Major therapeutic indications and metabolic routes of these drugs are reviewed. Changes in the logP values (determined and calculated) from the parent drug to the active metabolite show certain characteristics in comparison to...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012800840437

    authors: Hartyánszky I,Kalász H,Adeghate E,Gulyás Z,Hasan MY,Tekes K,Adem A,Sótonyi P

    更新日期:2012-07-01 00:00:00

  • Effects of dietary broccoli on human in vivo caffeine metabolism: a pilot study on a group of Jordanian volunteers.

    abstract:OBJECTIVES:Induction or inhibition of cytochrome P450 (CYP) enzyme activities, enzymes that activate or detoxify xenobiotics, is one mechanism by which vegetables may alter cancer risk. As the effect of food on CYP enzyme activities have not been studied in the Jordanian population, we examined the effect of supplement...

    journal_title:Current drug metabolism

    pub_type: 临床试验,杂志文章

    doi:10.2174/138920007779315080

    authors: Hakooz N,Hamdan I

    更新日期:2007-01-01 00:00:00

  • HIV-1 reverse transcriptase inhibitors: current issues and future perspectives.

    abstract::One of the major advances in the recent history of the treatment of HIV infections has been the development of different classes of effective antiretroviral drugs. In particular, the reverse transcriptase (RT) inhibitors still represent the majority of the clinically used anti-HIV drugs and constitute the main backbon...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200043335504

    authors: Locatelli GA,Cancio R,Spadari S,Maga G

    更新日期:2004-08-01 00:00:00

  • The prediction of the hepatic clearance of tanshinone IIA in rat liver subcellular fractions: accuracy improvement.

    abstract::The in vivo hepatic clearance of tanshinone IIA in the rat was predicted using microsome, cytosol and S9 fractions combined with two different cofactor systems, NADPH-regenerating and UDPGA system. Two different models, the well stirred model and the parallel-tube model, were used in predicting the in vivo clearance i...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920008783331103

    authors: Li P,Wang GJ,Li J,Zhang Q,Liu X,Khlentzos A,Roberts MS

    更新日期:2008-01-01 00:00:00

  • Oral L-carnitine: metabolite formation and hemodialysis.

    abstract::L-Carnitine has important roles in intermediary metabolism and patients with end-stage renal disease who are undergoing hemodialysis may develop a secondary L-carnitine deficiency. The extent of accumulation of the metabolites trimethylamine and trimethylamine-N-oxide when L-carnitine is administered orally has not be...

    journal_title:Current drug metabolism

    pub_type: 临床试验,杂志文章

    doi:10.2174/138920006778520561

    authors: Bain MA,Faull R,Milne RW,Evans AM

    更新日期:2006-10-01 00:00:00

  • Modulation and absorption of xenobiotics: the synergistic role of CYP450 and P-gp activities in cancer and neurodegenerative disorders.

    abstract::P-glycoprotein (P-gp) is involved in MDR and in neurodegenerative disorders such as Parkinson disease (PD), Alzheimer disease (AD) and epilepsy. Cytochrome P450 enzymes (CYP450s) catalyze the metabolism of a wide variety of endogenous and exogenous compounds including xenobiotics, drugs, environmental toxins, steroids...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920011798357015

    authors: Inglese C,Perrone MG,Berardi F,Perrone R,Colabufo NA

    更新日期:2011-10-01 00:00:00

  • Metabolism and disposition of the antiviral nucleoside analogue AM365 in the isolated perfused rat liver.

    abstract::The present study was designed to investigate the hepatic disposition of the prodrug AM365 and the generated antiviral guanosine analogue, AM188 in the isolated perfused rat liver (IPL). The livers of rats (n=12) were isolated and perfused with Krebs-Henseleit pH 7.4 buffer to which AM365 was added as a bolus to achie...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920005774330611

    authors: Wang J,Nation RL,Evans AM,Cox S,Shackleford D

    更新日期:2005-10-01 00:00:00

  • Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.

    abstract::With the advances in recombinant DNA biotechnology, molecular biology and immunology, the number of biotech drugs, including peptides, proteins and monoclonal antibodies, available for clinical use has dramatically increased in recent years. Although pharmacokinetic principles are equally applicable to the large molec...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009789895499

    authors: Lin JH

    更新日期:2009-09-01 00:00:00

  • Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.

    abstract:BACKGROUND:Thiopurine antimetabolites are important agents for the treatment of severe diseases, such as acute lymphoblastic leukemia and inflammatory bowel disease. Their pharmacological actions depend on biotransformation into active thioguanine-nucleotides; intracellular metabolism is mediated by enzymes of the salv...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160303104153

    authors: Pelin M,De Iudicibus S,Londero M,Spizzo R,Dei Rossi S,Martelossi S,Ventura A,Decorti G,Stocco G

    更新日期:2016-01-01 00:00:00

  • Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects

    abstract::We report here a comprehensive evaluation of the effects of culture duration on the gene expression of P450 isoforms, uptake transporters and efflux transporters in human hepatocyte cultured in the absence and presence of the prototypical proinflammatory cytokine, interleukin-6 (IL-6). Primary collagen-matrigel sandwi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920012802138570

    authors: Yang Q,Doshi U,Li N,Li AP

    更新日期:2012-09-01 00:00:00

  • Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance.

    abstract:BACKGROUND:Interleukin-28B (IL28B) locus on a human chromosomal region mapped to 19q13 execute immune defense against viruses. During Hepatitis C Virus (HCV) infection the IL28B has a promising role in deciding the consequence of infection for spontaneous clearance of viruses or causing chronic liver infection. Treatme...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180129115359

    authors: Asthana M,Sahu SK,Kumar A,Mohanty S,Chakrabarti S,Das P,Chattopadhya NR,Chatterjee K,Singh SP,Rajasubramaniam S,Choudhuri T

    更新日期:2018-01-01 00:00:00

  • Quantitative in vivo microdialysis in pharmacokinetic studies: some reminders.

    abstract::This paper reviews the empirical methods of quantitative microdialysis that have been used to interpret the results obtained from pharmacokinetic studies. The concept of extraction efficiency or recovery and the properties of recovery in vivo (variation with flow rate, time dependency and influence of the mode of admi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200053586109

    authors: Cano-Cebrián MJ,Zornoza T,Polache A,Granero L

    更新日期:2005-04-01 00:00:00

  • In vitro cytochrome P450 inhibition and induction.

    abstract::The assessment of in vitro inhibition and induction of the cytochrome P450 enzymes of the liver is a critical part of the drug discovery and development process in order to ensure that two or more drugs can be safely coadministered without alterations in exposure. Early assessment of potential candidates using high th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008786485128

    authors: Walsky RL,Boldt SE

    更新日期:2008-11-01 00:00:00

  • How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation.

    abstract::Infection with the human immunodeficiency virus type 1 (HIV) results in a chronic infection that progressively cripples the host immune defenses. HIV infection is associated with increased tryptophan (trp) catabolism by the cytokine-inducible enzyme indoleamine 2,3-dioxygenase (IDO). IDO has powerful immune suppressiv...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007780362527

    authors: Boasso A,Shearer GM

    更新日期:2007-04-01 00:00:00

  • Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery.

    abstract:BACKGROUND:The prolonged circulation time of nanoparticles in the blood is a prerequisite to realize a controlled and targeted (passive or active targeting) release of the encapsulated gene/drug at the desired site of action. The most popular method to mask or camouflage nanoparticles is the adsorbed, grafted or conjug...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666171207120643

    authors: Hu J,Sheng Y,Shi J,Yu B,Yu Z,Liao G

    更新日期:2018-01-01 00:00:00

  • Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf.

    abstract:BACKGROUND:Mutation in the B RAF at V600E has been well implicated in the carcinogenesis that makes it as an attractive therapeutictarget. In the present study, we sought to identify the basis of V600E mutation at functional and structural grounds. The study also endeavors in identification of small molecule as a poten...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200218666170503114611

    authors: Bandaru S,Sumithnath TG,Sharda S,Lakhotia S,Sharma A,Jain A,Hussain T,Nayarisseri A,Singh SK

    更新日期:2017-07-21 00:00:00

  • Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.

    abstract::Human genome sequencing highlights the involvement of genetic variation towards differential risk of human diseases, presence of different phenotypes, and response to pharmacological elements. This brings the field of personalized medicine to forefront in the era of modern health care. Numerous recent approaches have ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160804150959

    authors: Prakash S,Agrawal S

    更新日期:2016-01-01 00:00:00

  • The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions.

    abstract::This review provides a vista of the current opportunities and remaining challenges in the area of in vitro-in vivo extrapolation, with particular emphasis on drug binding terms in predictive models, which has been the source of much controversy. Although the importance of fu(inc) (fraction unbound in in vitro incubati...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776359266

    authors: Grime K,Riley RJ

    更新日期:2006-04-01 00:00:00

  • High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.

    abstract::Evaluation and optimization of drug metabolism and pharmacokinetic data plays an important role in drug discovery and development and several reliable in vitro ADME models are available. Recently higher throughput in vitro ADME screening facilities have been established in order to be able to evaluate an appreciable f...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008786485092

    authors: Hop CE,Cole MJ,Davidson RE,Duignan DB,Federico J,Janiszewski JS,Jenkins K,Krueger S,Lebowitz R,Liston TE,Mitchell W,Snyder M,Steyn SJ,Soglia JR,Taylor C,Troutman MD,Umland J,West M,Whalen KM,Zelesky V,Zhao SX

    更新日期:2008-11-01 00:00:00

  • Nanotechnology in Disease Diagnostic Techniques.

    abstract::Currently the major research highlights of bioengineering and medical technology are directed towards development of improved diagnostic techniques to screen complex diseases. Screening requirements are to identify the cause of illnesses, monitor improvement or progression of the state of diseases such as cancer, card...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Savaliya R,Shah D,Singh R,Kumar A,Shanker R,Dhawan A,Singh S

    更新日期:2015-01-01 00:00:00

  • Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.

    abstract::The pharmacological effects of a drug are highly dependent on the absorption, metabolism, elimination, and distribution of the drug. In the past few years it has become apparent that transport proteins play a major role in regulating the distribution, elimination and metabolism of some drugs. As a consequence of our n...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200023337559

    authors: Hochman JH,Yamazaki M,Ohe T,Lin JH

    更新日期:2002-06-01 00:00:00

  • Functional expression of human cytochrome P450 enzymes in Escherichia coli.

    abstract::Knowledge regarding cytochrome P450 (P450) is crucial to the fields of drug therapy and drug development, as well as in our understanding of the mechanisms underlying the metabolic activation of potentially toxic and carcinogenic compounds. Escherichia coli is the most extensively utilized host in the production of re...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776873472

    authors: Yun CH,Yim SK,Kim DH,Ahn T

    更新日期:2006-05-01 00:00:00

  • Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs.

    abstract::In the recent decades, the use of herbal products has been rapidly growing in the Western countries. While their use in many cases causes adverse effects, to date, safety issues of herbal products have not been adequately addressed. It is rarely determined whether the non-purported bioactive constituents in the herbs ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011797470119

    authors: Li N,Xia Q,Ruan J,Fu PP,Lin G

    更新日期:2011-11-01 00:00:00

  • 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases.

    abstract::Arachidonic acid (AA) is metabolized by enzymes of the cytochrome P450 (CYP) 4A and CYP4F subfamilies to 20- hydroxyeicosatetraeonic acid (20-HETE), which plays an important role in the cardiovascular system. In the current work, we reviewed the formation of 20-HETE in different species by different CYPs; 20-HETE meta...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200211314060007

    authors: Elshenawy OH,Anwar-Mohamed A,El-Kadi AO

    更新日期:2013-07-01 00:00:00